Joshua J Gagne1, Robert J Glynn, Jerry Avorn, Raisa Levin, Sebastian Schneeweiss. 1. Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1620 Tremont Street, Suite 3030, Boston, MA 02120, USA. jgagne1@partners.org
Abstract
OBJECTIVE: To develop and validate a single numerical comorbidity score for predicting short- and long-term mortality, by combining conditions in the Charlson and Elixhauser measures. STUDY DESIGN AND SETTING: In a cohort of 120,679 Pennsylvania Medicare enrollees with drug coverage through a pharmacy assistance program, we developed a single numerical comorbidity score for predicting 1-year mortality, by combining the conditions in the Charlson and Elixhauser measures. We externally validated the combined score in a cohort of New Jersey Medicare enrollees, by comparing its performance to that of both component scores in predicting 1-year mortality, as well as 180-, 90-, and 30-day mortality. RESULTS: C-statistics from logistic regression models including the combined score were higher than corresponding c-statistics from models including either the Romano implementation of the Charlson Index or the single numerical version of the Elixhauser system; c-statistics were 0.860 (95% confidence interval [CI]: 0.854, 0.866), 0.839 (95% CI: 0.836, 0.849), and 0.836 (95% CI: 0.834, 0.847), respectively, for the 30-day mortality outcome. The combined comorbidity score also yielded positive values for two recently proposed measures of reclassification. CONCLUSION: In similar populations and data settings, the combined score may offer improvements in comorbidity summarization over existing scores.
OBJECTIVE: To develop and validate a single numerical comorbidity score for predicting short- and long-term mortality, by combining conditions in the Charlson and Elixhauser measures. STUDY DESIGN AND SETTING: In a cohort of 120,679 Pennsylvania Medicare enrollees with drug coverage through a pharmacy assistance program, we developed a single numerical comorbidity score for predicting 1-year mortality, by combining the conditions in the Charlson and Elixhauser measures. We externally validated the combined score in a cohort of New Jersey Medicare enrollees, by comparing its performance to that of both component scores in predicting 1-year mortality, as well as 180-, 90-, and 30-day mortality. RESULTS: C-statistics from logistic regression models including the combined score were higher than corresponding c-statistics from models including either the Romano implementation of the Charlson Index or the single numerical version of the Elixhauser system; c-statistics were 0.860 (95% confidence interval [CI]: 0.854, 0.866), 0.839 (95% CI: 0.836, 0.849), and 0.836 (95% CI: 0.834, 0.847), respectively, for the 30-day mortality outcome. The combined comorbidity score also yielded positive values for two recently proposed measures of reclassification. CONCLUSION: In similar populations and data settings, the combined score may offer improvements in comorbidity summarization over existing scores.
Authors: Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan Journal: Epidemiology Date: 2010-01 Impact factor: 4.822
Authors: Sebastian Schneeweiss; Jeremy A Rassen; Robert J Glynn; Jerry Avorn; Helen Mogun; M Alan Brookhart Journal: Epidemiology Date: 2009-07 Impact factor: 4.822
Authors: Quinn R Pack; Ray W Squires; Francisco Lopez-Jimenez; Steven W Lichtman; Juan P Rodriguez-Escudero; Peter K Lindenauer; Randal J Thomas Journal: J Cardiopulm Rehabil Prev Date: 2015 May-Jun Impact factor: 2.081
Authors: Michael D George; Brian C Sauer; Chia-Chen Teng; Grant W Cannon; Bryant R England; Gail S Kerr; Ted R Mikuls; Joshua F Baker Journal: J Rheumatol Date: 2018-10-01 Impact factor: 4.666
Authors: S C Kim; N Choudhry; J M Franklin; K Bykov; M Eikermann; J Lii; M A Fischer; B T Bateman Journal: Osteoarthritis Cartilage Date: 2017-04-19 Impact factor: 6.576
Authors: Joshua R Lakin; Margaret G Robinson; Rachelle E Bernacki; Brian W Powers; Susan D Block; Rebecca Cunningham; Ziad Obermeyer Journal: JAMA Intern Med Date: 2016-12-01 Impact factor: 21.873
Authors: Susan P Y Wong; Paul L Hebert; Ryan J Laundry; Kenric W Hammond; Chuan-Fen Liu; Nilka R Burrows; Ann M O'Hare Journal: Clin J Am Soc Nephrol Date: 2016-09-22 Impact factor: 8.237